Joe Paterson (@Crystec_Joe) header
Joe Paterson (@Crystec_Joe) profile picture
Joined March 2018
Photo by Joe Paterson (@Crystec_Joe)
Are you seeking a rapid pathway to develop an optimised inhaled therapy? Crystec's mSAS® technology can offer many advantages. Check out our latest article to learn more about our capabilities in this area. lnkd.in/d73Zxi9
3
4
This month Crystec has announced a new site in Haimen, continuing our expansion in China.
Crystec have opened a new R&D facility in Haimen, China, in collaboration with the Yangtze Delta Advanced Drug Development platform. Crystec’s mSAS® technology will play a key role in enabling the development of new therapeutics. Press release: https://teapawt.net/t.co/hWQJvn9mru
Crystec has recently been involved in a collaboration with SIMM, part of our continued development and growth in China.
Committed to collaboration and strategic partnerships in China, providing access to some of the best scientific facilities in the world, Crystec's Peter York recently contributed to a publication by SIMM providing new insights into inhaled drug development.https://teapawt.net/t.co/lkziF8K7zK
We're now in our second week of partnering for BIO-Europe
Partnering opened this week for #BIOEuropeSpring. If you are seeking innovative technologies to support your development programmes, whether by overcoming development challenges, optimising delivery or by enhancing IP, please get in touch to arrange a meeting.
2
Check out our latest article summarising mSAS® solutions for improving product stability! lnkd.in/e7B56zc For more information, please visit our website (lnkd.in/eycdTuN)
4
7
Crystec can apply a range of strategies to overcome poor solubility in pharmaceutical development. If you are seeking to improve drug dissolution, please read our latest article (lnkd.in/deF8N6x) to find out more about how we can help!
4
4
Watch this video to see why Crystec were shortlisted for the CPhI Excellence in Pharma Awards: Innovation in Response to Covid-19 youtu.be/0lQeIRbpVPo To learn more, visit our website or get in touch! https://teapawt.net/t.co/TGC9AJsDOo
3
2
Partnering has opened for #BIOEurope Digital (26-29 Oct)! Crystec would be delighted to meet to discuss how #mSAS® can help optimise product performance, while simplifying and accelerating your development journey. Please get in touch! https://teapawt.net/t.co/zIq8YRHp5d
3
3
Crystec are attending #CPhI #FestivalofPharma from 5-16 Oct 2020! Contact us to learn how #mSAS particle engineering can overcome development challenges, optimise product performance and add value to your therapeutic pipeline! https://teapawt.net/t.co/aIN3Q7rrpd #PerformaceInEveryParticle
ISAM appeal for decision makers to consider the inhaled route of administration when developing #COVID19 treatments . https://teapawt.net/t.co/WZRUKWbw4S If this relates to your R&D, please get in touch to learn how mSAS can enable optimised inhaled delivery https://teapawt.net/t.co/GgYrjNrWkx
Crystec are pleased to announce the recent approval of patents in China and Europe for our lead asset, CR002. This will be the first on-demand product for urge incontinence in the world, empowering patients to actively manage their condition. https://teapawt.net/t.co/JJDuU5YZJq #Innovation
1
3
3
Are you facing solubility challenges in your product development? Watch our video to see how Crystec’s mSAS® particle engineering platform can help! https://teapawt.net/t.co/QtoHm9AhKK Why not meet us at #BIODigital to find out more?
2
2
BIO is going digital from 8th - 12th June! To learn the latest developments on Crystec’s mSAS® technology, or if you are looking for crystallisation and particle engineering support for your programmes, please get in touch! https://teapawt.net/t.co/Qbdq7hp47R #BIODigital
3
2
Crystec are taking part in COVID-19 Virtual Partnering, a digital conference which aims to accelerate global collaboration for COVID-19 testing, treatment and prevention. To arrange a discussion please contact us through the partnering system #PartneringAgainstCovid19
2
2
Will you be in Paris for #BIOEuropeSpring in March? Partnering opens on Monday and Crystec would be delighted to meet to discuss how our mSAS® platform can add value to your programmes. Please contact us through the partnering system to schedule a meeting! crystecpharma.com/news/lates…
The @UniofBradford is hosting a launch event for Project CAYMAN, where Crystec’s Dr Lyn Daintree , will be talking about how the University’s Analytical Centre has supported us, strengthening our analytical capability. Come along this Wednesday! eventbrite.co.uk/e/erdf-proj…
3
4
CRYSTECPHARMA AND ICONOVO TO COLLABORATE IN DEVELOPMENT OF INNOVATIVE INHALER PRODUCTS CrystecPharma today announced that it signed a Letter of Understanding with Iconovo to collaborate in the development of innovative dry powder inhaler (DPI) products. buff.ly/36FO7GU
3
7
Crystec will be in Frankfurt for #CPhI2019 in under 2 weeks! Watch our video to see how our mSAS® technology platform can help overcome solubility challenges in BCS class II and IV drugs. buff.ly/32Hf4Yn Please get in touch to find out more, or to book a meeting at CPhI!
4 weeks until #CPhI and we’re excited to meet you. Why not book a meeting to learn how Crystec’s mSAS® technology can enable generation of uniform composite particles and scalable co-crystals, for optimised administration of combination products over a range of dosage forms?